What if you'd held STLN?
A $1,000 investment in Starling Oncology, Inc. (STLN) at the month-end close of 2020-06 would be worth $663 at the close of 2026-08 — -33.7% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $2,486.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2020
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2020 | $1,000 | — |
| 2021 | $903 | -9.7% |
| 2022 | $153 | -83.1% |
| 2023 | $189 | +23.6% |
| 2024 | $28.61 | -84.9% |
| 2025 | $330 | +1052.1% |
| 2026 | $617 | +87.1% |
Best and worst month-end to buy
The best single month-end close to have bought STLN was 2024-11 ($0.16): $1,000 then is $41,111 today. The worst was 2021-02 ($10.91): $1,000 then is $610.
FAQ
What would $1,000 in STLN be worth today?
A $1,000 investment in Starling Oncology, Inc. (STLN) at the start of 2020 would be worth about $663 today, a total return of -33.7%. Dividends are reinvested in these figures.
What were the best and worst years for STLN?
Starling Oncology, Inc. (STLN)'s strongest calendar year since 2020 was 2025, a +1052.1% return — $1,000 held through that year became about $11,521 by year-end. Its weakest year was 2024, at -84.9%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in STLN have grown?
Investing $100 at the end of every month since 2020-06 would have grown to about $35,401 on $7,500 invested.
Did STLN beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $2,486. STLN trailed the S&P 500 by +73.3% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Starling Oncology, Inc. (STLN) historical total-return data from 2020-06 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.